Luigi Della Gravara, Ciro Battiloro, Rosa Cantile, Antonietta Letizia, Fabiana Vitiello, Vincenzo Montesarchio, Danilo Rocco
{"title":"化疗和/或免疫检查点抑制剂在非小细胞肺癌一线:什么是最好的方法?","authors":"Luigi Della Gravara, Ciro Battiloro, Rosa Cantile, Antonietta Letizia, Fabiana Vitiello, Vincenzo Montesarchio, Danilo Rocco","doi":"10.2217/lmt-2019-0018","DOIUrl":null,"url":null,"abstract":"Luigi Della Gravara1, Ciro Battiloro2, Rosa Cantile2, Antonietta Letizia2, Fabiana Vitiello2, Vincenzo Montesarchio3 & Danilo Rocco*,2 1Department of Experimental Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Caserta, Italy 2Division of Pulmonary Oncology, AORN dei Colli Monaldi, Naples, Italy 3Division of Medical Oncology, AORN dei Colli Monaldi, Naples, Italy *Author for correspondence: danilorocc@yahoo.it","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/lmt-2019-0018","citationCount":"15","resultStr":"{\"title\":\"Chemotherapy and/or immune checkpoint inhibitors in NSCLC first-line setting: what is the best approach?\",\"authors\":\"Luigi Della Gravara, Ciro Battiloro, Rosa Cantile, Antonietta Letizia, Fabiana Vitiello, Vincenzo Montesarchio, Danilo Rocco\",\"doi\":\"10.2217/lmt-2019-0018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Luigi Della Gravara1, Ciro Battiloro2, Rosa Cantile2, Antonietta Letizia2, Fabiana Vitiello2, Vincenzo Montesarchio3 & Danilo Rocco*,2 1Department of Experimental Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Caserta, Italy 2Division of Pulmonary Oncology, AORN dei Colli Monaldi, Naples, Italy 3Division of Medical Oncology, AORN dei Colli Monaldi, Naples, Italy *Author for correspondence: danilorocc@yahoo.it\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0,\"publicationDate\":\"2020-02-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2217/lmt-2019-0018\",\"citationCount\":\"15\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/lmt-2019-0018\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/lmt-2019-0018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Chemotherapy and/or immune checkpoint inhibitors in NSCLC first-line setting: what is the best approach?
Luigi Della Gravara1, Ciro Battiloro2, Rosa Cantile2, Antonietta Letizia2, Fabiana Vitiello2, Vincenzo Montesarchio3 & Danilo Rocco*,2 1Department of Experimental Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Caserta, Italy 2Division of Pulmonary Oncology, AORN dei Colli Monaldi, Naples, Italy 3Division of Medical Oncology, AORN dei Colli Monaldi, Naples, Italy *Author for correspondence: danilorocc@yahoo.it
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
